These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31730577)
1. Highlights in Lymphoma From the 60th American Society of Hematology Annual Meeting: Commentary. Herrera AF Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 4(2):20-23. PubMed ID: 31730577 [No Abstract] [Full Text] [Related]
2. Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting: A hematologist's perspective. Haverkos B Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 3(2):18-20. PubMed ID: 31545305 [No Abstract] [Full Text] [Related]
3. Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting: A dermatologist's perspective. Geskin LJ Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 3(2):21-23. PubMed ID: 31545306 [No Abstract] [Full Text] [Related]
4. Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting: Commentary. Garcia-Manero G Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 5(2):16-19. PubMed ID: 31730587 [No Abstract] [Full Text] [Related]
5. Highlights in chronic lymphocytic leukemia from the 60th American Society of Hematology Annual Meeting: commentary. O'Brien SM Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 1(1):20-23. PubMed ID: 31545308 [No Abstract] [Full Text] [Related]
6. Highlights in Graft-vs-Host Disease From the 60th American Society of Hematology Annual Meeting: Commentary. Jagasia M Clin Adv Hematol Oncol; 2019 Mar; 17 Suppl 6(3):16-18. PubMed ID: 31730585 [No Abstract] [Full Text] [Related]
7. Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentary. Mesa RA Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 2(1):18-19. PubMed ID: 31545310 [No Abstract] [Full Text] [Related]
8. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Barr PM Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916 [No Abstract] [Full Text] [Related]
9. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Salles G Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858 [No Abstract] [Full Text] [Related]
10. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary. Straus DJ Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):20-23. PubMed ID: 33843910 [No Abstract] [Full Text] [Related]
11. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Evens AM Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922 [No Abstract] [Full Text] [Related]
12. Highlights in CAR T-Cell Therapy in Lymphoma From the 60th American Society of Hematology Annual Meeting: Commentary. Locke FL Clin Adv Hematol Oncol; 2019 May; 17 Suppl 10(5):20-23. PubMed ID: 32720926 [No Abstract] [Full Text] [Related]
13. Highlights in Lymphoma From the 60th American Society of Hematology Annual Meeting. Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 4(2):1-23. PubMed ID: 31730576 [No Abstract] [Full Text] [Related]
14. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915 [No Abstract] [Full Text] [Related]
15. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857 [No Abstract] [Full Text] [Related]
16. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting. Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):1-24. PubMed ID: 33843909 [No Abstract] [Full Text] [Related]
17. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921 [No Abstract] [Full Text] [Related]
18. Highlights in CAR T-Cell Therapy in Lymphoma From the 60th American Society of Hematology Annual Meeting. Clin Adv Hematol Oncol; 2019 May; 17 Suppl 10(5):1-23. PubMed ID: 32720925 [No Abstract] [Full Text] [Related]
19. Highlights in lymphoma from the 2016 American Society of Hematology annual meeting and exposition: Commentary. Horwitz SM Clin Adv Hematol Oncol; 2017 Feb; 15 Suppl 1(2):20-23. PubMed ID: 28590460 [No Abstract] [Full Text] [Related]
20. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting: commentary. Garcia-Manero G Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):18-22. PubMed ID: 33843920 [No Abstract] [Full Text] [Related] [Next] [New Search]